Lung transplantation is a treatment option for end-stage lung disease for which no other therapeutic options exist. Pleural space complications are common following lung transplantation, with a reported incidence of 22%-34%. 1 Pleural drains are placed surgically after lung transplantation to drain pleural fluid. The etiology of this pleural fluid may be multifactorial, and potential mechanisms for pleural fluid production include disruption of lymphatic drainage, increased alveolar-capillary permeability resulting from graft ischemia, denervation, and reperfusion, and overhydration. 2,3 In addition to expected post-operative pleural effusions, other pleural complications such as hemothorax, chylothorax, pneumothorax, empyema, trapped lung, and acute rejection may also occur.Typically, the amount of pleural fluid declines in the first week following transplant and resolves around day 9. 4 However, some patients may develop late pleural effusions (14-90 days following transplant) which may resolve with thoracentesis. 5 The use of smallbore drainage catheters to drain pleural effusions post-lung transplantation using ultrasound and CT guidance has also been reported in a small series of 31 patients up to 36 months after transplant. 6 In 9 of these patients, streptokinase was also administered when fluid increased despite catheter drainage or if the fluid was loculated.
AbstractBackground: This study aimed to investigate the characteristics of lung transplant recipients requiring additional pleural drainage catheters early post-lung transplantation and to determine the safety and efficacy of intrapleural fibrinolytics in these patients.
Methods:A retrospective review of lung transplant recipients at a single center was performed. Patient and transplant characteristics, placement of pleural drainage catheters within 90 days of transplant, and use of intrapleural fibrinolytics were determined.